1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. California >
  6. Concentra Biosciences Acquires Kronos Bio

M&A Deal Summary

Concentra Biosciences Acquires Kronos Bio

On May 1, 2025, Concentra Biosciences acquired life science company Kronos Bio for 35M USD

Acquisition Highlights
  • This is Concentra Biosciences’ 4th transaction in the Life Science sector.
  • This is Concentra Biosciences’ largest (disclosed) transaction.
  • This is Concentra Biosciences’ 4th transaction in the United States.
  • This is Concentra Biosciences’ 2nd transaction in California.

M&A Deal Summary
Date 2025-05-01
Target Kronos Bio
Sector Life Science
Buyer(s) Concentra Biosciences
Deal Type Merger
Deal Value 35M USD
Advisor(s) Leerink Partners (Financial)
Goodwin Procter
Gibson, Dunn & Crutcher (Legal)

Target

Kronos Bio

San Mateo, California, United States
Kronos Bio is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Kronos Bio was founded in 2017 and is based in San Mateo, California.

Search 207,728 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Concentra Biosciences

San Diego, California, United States
Category Company
Sector Life Science
DESCRIPTION

Concentra Biosciences is a biosciences company that serves clients around the US. Concentra Biosciences is based in San Diego, California.

DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 4 of 4
Type: Merger M&A Deals 3 of 3
State: California M&A 2 of 2
Country: United States M&A 4 of 4
Year: 2025 M&A 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-04-02 Allakos

San Carlos, California, United States

Allakos is a clinical-stage biotechnology company developing therapies to treat various allergic and inflammatory diseases. Allakos is primarily focused on eosinophilic gastrointestinal disorders (EGIDs), leveraging industry-leading expertise in eosinophil and mast cell biology. Allakos was founded in 2012 and is based in San Carlos, California.

Buy -
Mergr

Solution for

Product

Company

Legal